TRPM2 and neuroblastoma: SH-SY5Y neuroblastoma cells in which TRPM2 was deleted with CRISPR technology demonstrated significantly reduced proliferation compared to scrambled control cells, quantitated with trypan blue exclusion (Fig. 1A) or XTT analysis (Fig. 1B).